Alexander Hardy

CIK: 0002001910

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (44.4%)

Compensation grants

Other (G, F, J, C, D, …)5 (55.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BMRN

BIOMARIN PHARMACEUTICAL INC

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

BMRN
BIOMARIN PHARMACEUTICAL INC
Mar 17, 2026
Tax Payment(F)
Direct
4.3K shares at avg. $56.05$238K
BMRN
BIOMARIN PHARMACEUTICAL INC
Mar 16, 2026
Award(A)
Direct
62.4K shares-
BMRN
BIOMARIN PHARMACEUTICAL INC
Mar 13, 2026
Tax Payment(F)
Direct
2.9K shares at avg. $58.51$172K
BMRN
BIOMARIN PHARMACEUTICAL INC
Dec 1, 2025
Tax Payment(F)
Direct
16.6K shares at avg. $55.03$912K
BMRN
BIOMARIN PHARMACEUTICAL INC
Apr 30, 2025
Award(A)
Direct
375 shares at avg. $54.14$20K
BMRN
BIOMARIN PHARMACEUTICAL INC
Mar 17, 2025
Award(A)
Direct
44.4K shares-
BMRN
BIOMARIN PHARMACEUTICAL INC
Mar 14, 2025
Tax Payment(F)
Direct
2.9K shares at avg. $69.44$204K
BMRN
BIOMARIN PHARMACEUTICAL INC
Nov 29, 2024
Tax Payment(F)
Direct
14.3K shares at avg. $66.03$944K
BMRN
BIOMARIN PHARMACEUTICAL INC
Oct 31, 2024
Award(A)
Direct
300 shares at avg. $56.01$17K

		Type	Shares	Price		Ownership
Mar 17, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Tax Payment(F)	4,252	$56.05	$238,325	Direct
Mar 16, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	62,440	-	$0	Direct
Mar 13, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Tax Payment(F)	2,941	$58.51	$172,078	Direct
Dec 1, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Tax Payment(F)	16,570	$55.03	$911,847	Direct
Apr 30, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	375	$54.14	$20,301	Direct
Mar 17, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	44,360	-	-	Direct
Mar 14, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Tax Payment(F)	2,933	$69.44	$203,668	Direct
Nov 29, 2024	BMRN BIOMARIN PHARMACEUTICAL INC	Tax Payment(F)	14,295	$66.03	$943,899	Direct
Oct 31, 2024	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	300	$56.01	$16,802	Direct

1-9 of 9 transactions

About Hardy Alexander

Hardy Alexander (SEC CIK 0002001910) files insider reports with the SEC as Chief Executive Officer of BIOMARIN PHARMACEUTICAL INC (BMRN).

Signal8 holds 5 ownership filings by Hardy Alexander, all Form 4s, filed between Dec 3, 2024 and Mar 19, 2026. Those filings report 9 transactions, from Oct 31, 2024 to Mar 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hardy Alexander's filings is in SAN RAFAEL, CA.

Recent filings by Hardy Alexander

Mar 17, 2026: Tax withholding of BMRN shares (Form 4, code F).
Mar 16, 2026: Grant or award of BMRN shares (Form 4, code A).
Mar 13, 2026: Tax withholding of BMRN shares (Form 4, code F).
Dec 1, 2025: Tax withholding of BMRN shares (Form 4, code F).
Apr 30, 2025: Grant or award of BMRN shares (Form 4, code A).

Other insiders filing for BIOMARIN PHARMACEUTICAL INC (BMRN)

Friberg Gregory R, EVP, Chief R&D Officer
Plenge Robert M, Director
Davis George Eric, EVP, Chief Legal Officer
Countouriotis Athena, Director
Walbert Timothy P, Director
Ho Maykin, Director

How to read Form 4 transaction codes